0001179110-20-009277.txt : 20200824 0001179110-20-009277.hdr.sgml : 20200824 20200824183818 ACCESSION NUMBER: 0001179110-20-009277 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200820 FILED AS OF DATE: 20200824 DATE AS OF CHANGE: 20200824 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WORBOYS PHILIP D CENTRAL INDEX KEY: 0001668718 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36033 FILM NUMBER: 201129065 MAIL ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Theravance Biopharma, Inc. CENTRAL INDEX KEY: 0001583107 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET CITY: GEORGE TOWN, GRAND CAYMAN STATE: E9 ZIP: KY1-1104 BUSINESS PHONE: 650-808-6000 MAIL ADDRESS: STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET CITY: GEORGE TOWN, GRAND CAYMAN STATE: E9 ZIP: KY1-1104 4 1 edgar.xml FORM 4 - X0306 4 2020-08-20 0 0001583107 Theravance Biopharma, Inc. TBPH 0001668718 WORBOYS PHILIP D C/O THERAVANCE BIOPHARMA US, INC. 901 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080 0 1 0 0 SVP, Research & Transl Science Ordinary Shares 2020-08-20 4 S 0 17103 18.00 D 333252 D Ordinary Shares 2020-08-20 4 F 0 4804 18.22 D 328448 D Brett A. Grimaud, Attorney-in-Fact 2020-08-24